Common use of De-identified Information Clause in Contracts

De-identified Information. BA may use and disclose de-identified health information if (i) the use is disclosed to CE in writing and permitted in writing by CE in its sole discretion and (ii) the de-identification is in compliance with 45 C.F.R. §164.502(d), and the de-identified health information meets the standard and implementation specifications for de- identification under 45 C.F.R. §164.514(a) and (b).

De-identified Information. BA may use and disclose de-identified health information if (i) the use is disclosed to CE in writing and permitted in writing by CE in its sole discretion and (ii) the de-identification is in compliance with 45 C.F.R. CFR §164.502(d), and the de-identified health information meets the standard and implementation specifications for de- identification under 45 C.F.R. CRF §164.514(a) and (b).

De-identified Information. BA may not de-identify PHI without CE’s prior written consent. BA may only use and disclose de-identified health information if (i) the use is disclosed to CE and permitted by CE in writing and permitted in writing by CE in its sole discretion and (ii) the de-de- identification is in compliance with 45 C.F.R. §§ 164.502(d), and the de-identified health information meets the standard standards and implementation specifications for de- de-identification under 45 C.F.R. §§ 164.514(a) and (b).

De-identified Information. BA may use and disclose de-identified health information if (i) the use is disclosed to CE in writing and permitted in writing by CE in its sole discretion and (ii) the de-identification is in compliance with 45 C.F.R. §§ 164.502(d), and the de-identified health information meets the standard and implementation specifications for de- identification under 45 C.F.R. §§ 164.514(a) and (b).